Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CD98hc-targeted antibody shuttles for central nervous system delivery with broad cross-species reactivity.

Nature biomedical engineering·2026
Same author

ANARCII enables alignment-free antigen receptor numbering using a generalised language model.

Communications biology·2026
Same author

Benchmarking and behavioral characterization of LLM agents for protein design.

bioRxiv : the preprint server for biology·2026
Same author

Machine learning predictions of IgG1 and IgG4 self-association and high-concentration solution properties.

mAbs·2026
Same author

iNOS modulates inflammatory responses in an NO-independent manner through direct interaction with IRG1 in mitochondria.

Nature metabolism·2026
Same author

JAX Animal Behavior System (JABS), a genetics-informed, end-to-end advanced behavioral phenotyping platform for the laboratory mouse.

eLife·2026

Related Experiment Video

Updated: Feb 24, 2026

Rapid Antibody Glycoengineering in Chinese Hamster Ovary Cells
06:53

Rapid Antibody Glycoengineering in Chinese Hamster Ovary Cells

Published on: June 2, 2022

3.8K

Ginkgo Datapoints Antibody Developability Competition outcomes: limited model performance and a call for data

Lood van Niekerk1, Joshua Moller1, Seth Ritter1

  • 1Ginkgo Bioworks Inc, Boston, MA, USA.

Mabs
|February 22, 2026
PubMed
Summary

The Antibody Developability (AbDev) Competition benchmarked prediction models for antibody properties. Current models overfit small datasets, limiting generalization and highlighting the need for larger, standardized experimental data for antibody discovery.

Keywords:
Antibodycompetitiondevelopability

More Related Videos

Profiling Anti-Neu5Gc IgG in Human Sera with a Sialoglycan Microarray Assay
09:13

Profiling Anti-Neu5Gc IgG in Human Sera with a Sialoglycan Microarray Assay

Published on: July 13, 2017

10.0K
Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
09:17

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Published on: September 13, 2022

2.8K

Related Experiment Videos

Last Updated: Feb 24, 2026

Rapid Antibody Glycoengineering in Chinese Hamster Ovary Cells
06:53

Rapid Antibody Glycoengineering in Chinese Hamster Ovary Cells

Published on: June 2, 2022

3.8K
Profiling Anti-Neu5Gc IgG in Human Sera with a Sialoglycan Microarray Assay
09:13

Profiling Anti-Neu5Gc IgG in Human Sera with a Sialoglycan Microarray Assay

Published on: July 13, 2017

10.0K
Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
09:17

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma

Published on: September 13, 2022

2.8K

Area of Science:

  • Biotechnology
  • Computational Biology
  • Drug Discovery

Background:

  • Antibody developability is crucial for successful drug development.
  • Predicting antibody developability computationally is an active area of research.
  • Existing datasets for model training are often small and heterogeneous.

Purpose of the Study:

  • To benchmark computational models for predicting antibody developability.
  • To assess the generalization capabilities of these models on unseen data.
  • To identify limitations and future directions for antibody developability prediction.

Main Methods:

  • Conducted the blinded Ginkgo Datapoints Antibody Developability (AbDev) Competition.
  • Evaluated predictors on five biophysical properties: hydrophobicity, thermostability, self-association, expression titer, and polyreactivity.
  • Used a public training set (246 antibodies) and a held-out test set (80 antibodies).

Main Results:

  • Top performance varied by property, with hydrophobicity prediction being strongest (Spearman's ρ = 0.708).
  • Cross-validation scores on training data consistently outperformed test set performance, indicating overfitting.
  • Limited out-of-distribution generalization was observed across predictors.

Conclusions:

  • Current antibody developability models show limited generalization due to small, heterogeneous datasets.
  • Larger, standardized, and diverse experimental datasets with harmonized protocols are essential for robust model training and validation.
  • Future antibody discovery campaigns require reliable, generalizable developability prediction models.